Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Inhibikase Therapeutics
Inhibikase Therapeutics
Inhibikase, FDA find common ground to lift hold on Parkinson's drug
Fierce Biotech
Wed, 01/25/23 - 10:43 pm
Inhibikase Therapeutics
Parkinson's Disease
IkT-148009
clinical trials
Inhibikase stock sinks on FDA's unexpected clinical hold for lead asset's Parkinson's trial
Fierce Biotech
Mon, 11/7/22 - 10:44 am
Inhibikase Therapeutics
Parkinson's Disease
IkT-148009
Inhibikase doses first subject in Phase IIa Parkinson’s treatment trial
Clinical Trials Arena
Wed, 08/24/22 - 10:38 am
Inhibikase Therapeutics
clinical trials
Parkinson's Disease
IkT-148009
Inhibikase Therapeutics slahes deal size ahead of IPO
Fierce Biotech
Wed, 11/4/20 - 10:27 am
Inhibikase Therapeutics
IPOs